Physician profile
Daniel L Heithold
NPI 1588664106
$9,144.80
in general payments reported to CMS, 2019-2025
27 companies · $530 in 2025
The $530 reported for 2025 was more than what a typical Surgery provider received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $4,537 · 2020: $220 · 2021: $229 · 2022: $833 · 2023: $981 · 2024: $1,815 · 2025: $530.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,668 · Travel and Lodging: $657.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,668.27 |
| Travel and Lodging | $657.23 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $5,032.21 | 2019-2024 | Da Vinci Surgical System |
| Medtronic, INC. | $2,113.92 | 2023-2025 | Progrip, Signia, Transorb |
| Smith+Nephew, INC. | $800.94 | 2019-2025 | Grafix, Oasis, Stravix Pl |
| Lifenet Health | $247.39 | 2023-2025 | Theragenesis Wound Matrix |
| Integra Lifesciences Corporation | $149.04 | 2022-2025 | Integra, Integra Dermal Regeneration Template, Primatrix |
| Conmed Corporation | $135.80 | 2024 | Airseal |
| Sanara Medtech INC. | $57.45 | 2022-2024 | Celleraterx |
| Paratek Pharmaceuticals, INC. | $56.09 | 2019 | |
| Bioventus LLC | $54.41 | 2022 | |
| Surgical Specialties Corporation (US), INC. (Dba Corza Medical) | $52.98 | 2024 | |
| Baxter Healthcare | $49.97 | 2025 | Tisseel |
| Abbvie INC. | $44.82 | 2021-2025 | |
| Organogenesis INC. | $43.16 | 2019-2022 | |
| Mesh Suture INC | $38.27 | 2025 | |
| Solventum Corporation | $37.90 | 2025 | V.A.C. Veraflo, V.A.C.Ulta, V.A.C. Veraflo Cleanse Choice |
Show all 27 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ethicon US, LLC | $32.62 | 2020-2022 | |
| Tela Bio, INC. | $28.50 | 2023 | Ovitex Reinforced Bioscaffold With Permanent Polymer (Ovitex) |
| Osiris Therapeutics INC. | $25.75 | 2019 | |
| Acera Surgical, INC. | $23.91 | 2025 | Restrata Wound Matrix |
| Endogastric Solutions, INC | $21.53 | 2022 | |
| Asensus Surgical, INC. | $15.87 | 2019 | |
| Boston Scientific Corporation | $15.45 | 2021 | |
| Allergan, INC. | $15.21 | 2019 | |
| Covidien Lp | $14.29 | 2019 | |
| Convatec INC. | $14.11 | 2022 | |
| Stryker Corporation | $14.04 | 2022 | |
| Kerecis Limited | $9.17 | 2024 | Kerecis Omega3 Marigen, Kerecis Omega3 Graftguide, Kerecis Omega3 Surgiclose |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Daniel Heithold listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.